Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ono Pharmaceutical Co Ltd

+ Add to Watchlist

4528:JP

13,570.0 JPY 600.0 4.63%

As of 02:00:00 ET on 05/28/2015.

Snapshot for Ono Pharmaceutical Co Ltd (4528)

Open: 13,290.0 Day's Range: 13,260.0 - 13,630.0 Volume: 702,900
Previous Close: 12,970.0 52wk Range: 7,710.0 - 14,550.0 1-Yr Rtn: +76.74%

Stock Chart for 4528

No chart data available.
  • 4528:JP 13,580.0
  • 1D
  • 1M
  • 1Y
12,970.0
Interactive 4528 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4528

Current P/E Ratio (ttm) 110.8669
Estimated P/E(03/2016) 92.9573
Relative P/E vs. TPX 5.8437
Earnings Per Share (JPY) (ttm) 122.3990
Est. EPS (JPY) (03/2016) 145.9810
Est. PEG Ratio 2.1117
Market Cap (M JPY) 1,599,190.58
Shares Outstanding (M) 117.85
30 Day Average Volume 332,653
Price/Book (mrq) 3.0570
Price/Sale (ttm) 10.5951
Dividend Indicated Gross Yield 1.33%
Cash Dividend (JPY) 90.0000
Dividend Ex-Date 09/28/2015
5 Year Dividend Growth 0.00%
Next Earnings Announcement 08/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4528

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4528

ONO PHARMACEUTICAL CO., LTD. manufactures and sells pharmaceuticals. The Company mainly researches and develops prescription drugs.

Gyo SagaraPresident/CEOHiroshi AwataExecutive Vice President
Takashi SanoSenior Managing Exec OfficerKazuhito KawabataManaging Executive Officer
More Company Profile & Key Executives for 4528

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil